You are here

MPDL3280A

10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15

TheStreet.com

Fri, 05/15/15 - 11:05 am

Bristol-Myers Squibb

A preview of the new lung cancer data Roche will debut at ASCO

BioPharma Dive

Fri, 05/15/15 - 09:34 am

non-small cell lung cancer

PDL-1 inhibitors

Roche immunotherapy improves lung cancer survival

Yahoo/Reuters

Thu, 05/14/15 - 09:51 am

cancer immunotherapy

FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy

Bidness Etc.

Tue, 02/3/15 - 09:07 am

breakthrough therapies

non-small cell lung cancer

Roche, Merck extend immunotherapy fight to breast cancer

Yahoo/Reuters

Fri, 10/17/14 - 10:08 am

Bristol Defends Data; Roche Shines In Cancer Showdown

Investors.com

Mon, 06/2/14 - 02:51 pm

Bristol-Myers Squibb

Investigational immunotherapy anti-PDL1 (MPDL3280A) shrank tumours in 43 percent of people with a specific type of metastatic bladder cancer in a Roche study

Pipeline Review

Sun, 06/1/14 - 11:48 am

Roche Immune Therapy Drug Helps Bladder Cancer Patients

Bloomberg

Thu, 05/15/14 - 11:00 am

Cancer immunotherapies turn a corner in race to megablockbuster market

Fierce Biotech

Wed, 10/2/13 - 10:54 am

cancer immunotherapy

Bristol-Myers Squibb

Roche to show investors strength in and beyond cancer drugs

Yahoo/Reuters

Tue, 10/1/13 - 08:41 am

antibody conjugates

Roche's new round of lung cancer data keeps spotlight on immunotherapies

Fierce Biotech

Mon, 09/30/13 - 05:00 pm

non-small cell lung cancer

Roche immunotherapy drug may be "game changer" in lung cancer

Yahoo/Reuters

Sun, 09/29/13 - 01:50 pm

Roche immunotherapy shows response over range of cancers

Reuters

Thu, 05/16/13 - 10:22 am